Eli Lilly And Co (NYSE:LLY) has today announced that it would be lowering the price of two of its insulin pens. The change implies that it will be selling those pens at half the price it has been selling its branded versions. The pens and the pricing The company outlines that the two pens will […]
Mike Mason
Recent Posts
Odyssey Health, Inc. Makes Statement Regarding its Concussion Drug Development Program
Gourmet Provisions International Corp. (GMPR) Announces Maryland Save a Lot Grocery Stores Locations
Green Stream Holdings Inc (GSFI) Sees Opportunity For Community Solar Projects in California
GPOPlus+ Enters Into Distribution Agreement with CaliGold Distro
GPOPlus+ Engages North Equities Corp. to Provide Digital Marketing Services
